科兴生物董事会建议股东拒绝Alternative Liquidity的要约收购

界面01-18

1月18日，科兴控股生物技术有限公司（NASDAQ: SVA）发布公告称，董事会一致决定，Alternative Liquidity Index LP（下称Alternative Liquidity）提出的以每股0.03美元现金收购至多1000万股Sinovac普通股的部分要约收购不可取，也不符合公司的最佳利益。因此，董事会建议股东拒绝接受要约收购，不根据Alternative Liquidity...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2404586094?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-01-18 20:47","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2404586094","market":"us","top_or_hot":-1,"title":"科兴生物董事会建议股东拒绝Alternative Liquidity的要约收购","media":"界面","content":"<div>\n<p>1月18日，科兴控股生物技术有限公司（NASDAQ: SVA）发布公告称，董事会一致决定，Alternative Liquidity Index LP（下称Alternative Liquidity）提出的以每股0.03美元现金收购至多1000万股Sinovac普通股的部分要约收购不可取，也不符合公司的最佳利益。因此，董事会建议股东拒绝接受要约收购，不根据Alternative Liquidity...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401182047167a3c4c5d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>科兴生物董事会建议股东拒绝Alternative Liquidity的要约收购</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n科兴生物董事会建议股东拒绝Alternative Liquidity的要约收购\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-01-18 20:47 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401182047167a3c4c5d&s=b><strong>界面</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>1月18日，科兴控股生物技术有限公司（NASDAQ: SVA）发布公告称，董事会一致决定，Alternative Liquidity Index LP（下称Alternative Liquidity）提出的以每股0.03美元现金收购至多1000万股Sinovac普通股的部分要约收购不可取，也不符合公司的最佳利益。因此，董事会建议股东拒绝接受要约收购，不根据Alternative Liquidity...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401182047167a3c4c5d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401182047167a3c4c5d&s=b","article_id":"2404586094","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401182047167a3c4c5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2404586094","pubTimestamp":1705582036,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"1月18日，科兴控股生物技术有限公司发布公告称，董事会一致决定，Alternative Liquidity Index LP提出的以每股0.03美元现金收购至多1000万股Sinovac普通股的部分要约收购不可取，也不符合公司的最佳利益。因此，董事会建议股东拒绝接受要约收购，不根据Alternative Liquidity的收购要约投标其股份。根据公告，Alternative Liquidity承认，它没有任何准确的方法来确定公司股份的现值。科兴董事会认为，这说明Alternative Liquidity的估值方法缺乏可信度，要约收购价格也不充分。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","SVA":"科兴生物"},"translate_title":"The board of directors of Sinovac Biotech recommended that shareholders reject the tender offer of Alternative Liquidity","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SVA":1},"content_text":"1月18日，科兴控股生物技术有限公司（NASDAQ: SVA）发布公告称，董事会一致决定，Alternative Liquidity Index LP（下称Alternative Liquidity）提出的以每股0.03美元现金收购至多1000万股Sinovac普通股的部分要约收购不可取，也不符合公司的最佳利益。因此，董事会建议股东拒绝接受要约收购，不根据Alternative Liquidity的收购要约投标其股份。根据公告，Alternative Liquidity承认，它没有任何准确的方法来确定公司股份的现值。Alternative Liquidity声称，“没有进行或委托进行任何评估，也未聘请任何独立财务顾问或其他第三方对股票价值进行任何估值分析或提供任何意见”。科兴董事会认为，这说明Alternative Liquidity的估值方法缺乏可信度，要约收购价格也不充分。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2404586094"}